- Previous Close
1.1500 - Open
1.2000 - Bid 1.1000 x --
- Ask 1.1100 x 40000
- Day's Range
1.1000 - 1.2400 - 52 Week Range
0.4700 - 1.2400 - Volume
73,132 - Avg. Volume
21,939 - Market Cap (intraday)
38.86M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Quantumzyme Corp. operates as a biotransformation company. It develops engineered enzymes for use in active pharmaceutical ingredients production. The company was formerly known as Reliant Services, Inc. and changed its name to Quantumzyme Corp. in March 2023. The company was incorporated in 2015 and is based in San Diego, California.
www.quantumzymecorp.comRecent News: QTZM
View More
Performance Overview: QTZM
Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: QTZM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: QTZM
View MoreValuation Measures
Market Cap
40.63M
Enterprise Value
40.63M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--